S&P 500
(0.01%) 5 249.24 points
Dow J
(0.00%) 39 759 points
Nasdaq
(-0.13%) 16 378 points
Oil
(1.22%) $82.34
Gas
(1.22%) $1.739
Gold
(0.64%) $2 226.90
Silver
(0.06%) $24.77
Platinum
(1.12%) $919.90
USD/EUR
(0.22%) $0.925
USD/NOK
(0.59%) $10.83
USD/GBP
(0.01%) $0.791
USD/RUB
(-0.40%) $92.07

Realtime updates for Cogint Inc. [COGT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
62.50%
return 59.44%
SELL
42.86%
return 5.38%
Last Updated28 Mar 2024 @ 10:23

-1.08% $ 6.45

SELL 61574 min ago

@ $8.60

Issued: 14 Feb 2024 @ 15:09


Return: -25.00%


Previous signal: Feb 14 - 12:47


Previous signal: Buy


Return: -2.05 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 10:23):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors...

Stats
Today's Volume 61 062.00
Average Volume 2.23M
Market Cap 670.24M
EPS $0 ( 2024-03-12 )
Next earnings date ( $-0.500 ) 2024-05-14
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.67
ATR14 $0.0300 (0.47%)
Insider Trading
Date Person Action Amount type
2024-02-16 Fairmount Funds Management Llc Buy 1 166 666 Common Stock
2024-02-16 Fairmount Funds Management Llc Buy 1 500 Series B Convertible Preferred Stock
2024-01-23 Robinson John Edward Buy 300 000 Stock Option (Right to Buy)
2024-01-23 Kearns Evan Buy 255 000 Stock Option (Right to Buy)
2024-01-23 Sachs Jessica Buy 300 000 Stock Option (Right to Buy)
INSIDER POWER
100.00
Last 97 transactions
Buy: 19 240 363 | Sell: 1 265 393

Volume Correlation

Long: 0.03 (neutral)
Short: 0.63 (weak)
Signal:(42.233) Neutral

Cogint Inc. Correlation

10 Most Positive Correlations
NWL0.911
CPIX0.903
PRAX0.9
CNDT0.891
EWTX0.89
QMCO0.887
AQB0.886
AVDX0.886
SRTS0.885
CHB0.885
10 Most Negative Correlations
PPBT-0.881
FIZZ-0.864
EPZM-0.833
SNCR-0.822
XOG-0.821
TYHT-0.816
LEDS-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cogint Inc. Correlation - Currency/Commodity

The country flag 0.36
( neutral )
The country flag -0.05
( neutral )
The country flag 0.00
( neutral )
The country flag -0.02
( neutral )
The country flag 0.00
( neutral )
The country flag -0.32
( neutral )

Cogint Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-3.59M (0.00 %)
EPS: $-2.42
Q4 2023
Revenue: $0
Gross Profit: $-794 000 (0.00 %)
EPS: $-0.630
Q3 2023
Revenue: $0
Gross Profit: $-855 000 (0.00 %)
EPS: $-0.640
Q2 2023
Revenue: $0
Gross Profit: $-1.22M (0.00 %)
EPS: $-0.590

Financial Reports:

No articles found.

Cogint Inc.

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators